BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
51.30
0.12 (0.23%)
At close: Aug 15, 2025, 3:59 PM
51.00
-0.58%
After-hours: Aug 15, 2025, 07:58 PM EDT
BridgeBio Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -183.76M | -167.42M | -267.39M | -164.25M | -73.46M | -35.22M | -170.33M | -179.49M | -160.7M | -142.73M | -140.57M | -140.19M | -2.56M | -201.33M | -152.28M | -161.02M | -102.07M | -171.08M |
Depreciation & Amortization | 1.32M | 1.28M | 1.37M | 1.54M | 1.57M | 1.6M | 1.58M | 1.64M | 1.64M | 1.63M | 1.66M | 1.65M | 1.58M | 1.88M | 1.53M | 265K | 2.69M | 1.36M |
Stock-Based Compensation | 37.24M | 25.88M | 30.13M | 27.16M | 21.45M | 17.06M | 37.02M | 22.6M | 27.18M | 21.91M | 21.79M | 17.36M | 28.29M | 24.12M | 19.77M | 16.04M | 30.11M | 33.58M |
Other Working Capital | -4.53M | -20M | 20.93M | 1.28M | -3.18M | 14.47M | 15.79M | 617K | 13.87M | -28M | 10.37M | -8.24M | 34.55M | -8.26M | 19.13M | 28.04M | -37.19M | -17.21M |
Other Non-Cash Items | 45.1M | -58.98M | 27.62M | -42.87M | -121.31M | 282.14M | 7.22M | 3.09M | 6.51M | 6.67M | 12.13M | -7.11M | -91.04M | 24.76M | 1.86M | 6.78M | 3.51M | 6.34M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -22.3M | 5.62M | -1.55M | n/a | n/a | n/a | n/a | n/a | -25.38M | n/a | n/a | -5.55M |
Change in Working Capital | 19.42M | n/a | 12.95M | -2.14M | 246.44M | -225.2M | 21.98M | 1.31M | 13.57M | -31.8M | 11.75M | -6.87M | 33.28M | -10.07M | 20.6M | 16.37M | -25.95M | -15.42M |
Operating Cash Flow | -80.68M | -199.24M | -195.33M | -180.57M | 74.7M | -219.54M | -124.82M | -145.23M | -113.35M | -144.32M | -93.24M | -135.16M | -30.45M | -160.63M | -133.9M | -121.56M | -91.71M | -150.76M |
Capital Expenditures | -5.09M | n/a | -3.24M | -1.73M | -2.45M | -1.49M | -435K | -431K | -428K | -12K | -801K | -759K | -3.9M | -859K | -2.54M | -41.46M | -2.29M | -1.96M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -98K | n/a | -369K | -38.11M | -4.55M | -503K | -18.77M | -147.62M | 110M | 10M | 54.23M | 35M | -84.77M | n/a |
Purchase of Investments | -7.91M | n/a | n/a | n/a | -49.42M | -64.67M | -29.22M | -16.78M | -43.78M | -47.47M | -32.11M | -30.41M | -66.66M | -63.88M | -43.84M | -69.5M | -150.64M | -379.29M |
Sales Maturities Of Investments | n/a | n/a | n/a | 40M | 55M | 63.23M | 29.59M | 54.9M | 48.33M | 60.29M | 50.87M | 178.02M | 110.26M | 193.37M | 68.17M | 169.93M | 139.73M | 99.2M |
Other Investing Acitivies | -4.5M | -1.59M | -3.19M | -1.64M | -2.39M | 25.68M | 369K | 38.11M | 4.55M | -503K | 18.77M | 147.62M | 110M | 10M | -54.23M | -35M | 13.65M | -280.09M |
Investing Cash Flow | -13M | -1.59M | -3.24M | 38.23M | 3.04M | 22.75M | -66K | 37.68M | 4.12M | 12.3M | 17.96M | 146.86M | 149.7M | 138.62M | 21.8M | 58.97M | 458K | -282.05M |
Debt Repayment | 300M | 116M | 500M | n/a | -3.73M | -23.42M | n/a | n/a | n/a | n/a | n/a | n/a | -20.49M | n/a | 325.29M | n/a | 6.89M | 747.5M |
Common Stock Repurchased | -2M | -50.05M | -1.4M | -1.44M | -1.74M | -2.94M | -2.56M | -2.61M | -1.2M | -512K | -489K | -596K | -366K | -110K | -2.25M | -143.88M | -7.59M | -51.02M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -110.76M | n/a | n/a | n/a |
Other Financial Acitivies | 4.04M | 60.33M | -24.66M | 2.17M | 241K | -12.25M | -1.97M | 3.44M | -28K | 7.75M | 2.01M | 2.04M | 56K | -50K | 2.35M | 8.43M | -694K | -148.57M |
Financial Cash Flow | 302.04M | 60.33M | 473.93M | 707K | -5.73M | 279.55M | -4.52M | 307.04M | -1.23M | 150.25M | 6.38M | 1.45M | -20.8M | -160K | 325.38M | -135.46M | -1.39M | 547.91M |
Net Cash Flow | 208.36M | -140.5M | 275.37M | -141.63M | 72.01M | 82.77M | -129.41M | 199.5M | -110.47M | 18.23M | -68.9M | 13.14M | 98.45M | -22.17M | 213.29M | -198.05M | -92.65M | 115.09M |
Free Cash Flow | -85.78M | -199.24M | -198.56M | -182.3M | 72.26M | -221.03M | -125.25M | -145.66M | -113.78M | -144.33M | -94.04M | -135.92M | -34.35M | -161.49M | -136.43M | -163.02M | -94M | -152.73M |